A comparative study of Vamana Followed by Matrabasti in polycystic ovarian syndrome.

RANDOMIZED CONTROLLED CLINICAL STUDY TO EVALUATE THE EFFICACY OF VAMANA FOLLOWED BY LASHUNA TAILAM MATRA BASTI IN POLYCYSTIC OVARIAN SYNDROME.

Status

Active, not recruiting

Phases

Phase 2

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2021/01/030260

Enrollment

Registered

2021-01-05

Start date

Unknown

Completion date

Unknown

Last updated

2023-11-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E282- Polycystic ovarian syndrome

Interventions

Intervention1: Vaman followed by Matrabasti: Vamana Karma in all around 1 Month followed by Lashuna Tailam Matra Basti Treatment for 7 days in each of the 3 consecutive months. Intervention2: Vamana K

Eligibility

Inclusion criteria

Inclusion criteria: a) Female Patients between the reproductive age of 15-45 years b) Both unmarried and married females. c) Diagnosed cases of PCOS d) Patients with Irregular cycles ( >35 or e) Patients with Irregular menses/scanty menses due to anovulatory cycle. f) Patients with Signs and Symptoms of Artava Kshaya due to PCOS alone. g) Patients fit for Vamana Karma and Matra Basti treatment.

Exclusion criteria

Exclusion criteria: 1. Patients with abnormal menstrual cycle but not due to PCOS. 2. Patients with Amenorrhea, Hirsutism and Obesity but not due to PCOS. 3. Patients suffering from signs and symptoms of Artavakshaya Secondary to Hyper Thyroidisim, Tuberculosis, Anemia, Congenital Adrenal Hyperplasia, Androgen Secreting Tumors, Functional Hypothalamic Amenorrhea, Hyperprolactenaemia. 4. Patients with Cervical Tumor, Polyp, Carcinoma Cervix, Uterine Fibroids, Tuberculous Endometritis. 5. Patients with Cardiac Disorders, Congenital Anomalies of Reproductive Organs, Malignant Tumors of Reproductive Organs, Adrenal/Pituitary Tumors, Cushing Syndrome. 6. Patients on Cytotoxic drugs 7. Patients with HIV or Venereal diseases or Hepatitis B positive patients. 8. Patients associated with any other severe systemic illness. 9. Patient not fit for Vamana or Matra Basti Karmas.

Design outcomes

Primary

Measure	Time frame
h)Evaluation of reduction in Ayurvedic Signs and Symptoms of Artava Kshaya and Clinical Signs and Symptoms, and Sonological Imaging Parameters of Polycystic Ovary Syndrome (PCOS) with the help of Vamana Karma followed by Lashuna Tailam Matra Basti Treatment in Female Patients between the reproductive age of 15-45 years.Timepoint: 2 years	—

Secondary

Measure	Time frame
1 Regularization of Menstrual 2 Cycles Induction of Ovulation 3 Achieving Pregnancy 4 Reduction of Hyperandrogenism i.e. Hirsutism, Acne, Acanthosis Nigricans, Reduction in number and size of ovarian Cysts Weight Reduction. Timepoint: 2 years	—

Countries

India

Contacts

Public ContactDr Snehalata Shivajirao Pawar

Dr D Y Patil college of ayurved and research centre Pimpri pune

mamtaraut1966@gmail.com9028375851

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026